J. Goldberg

发表

In Vivo Augmentation of Tumor-Specific CTL Responses by Class I/Peptide Antigen Complexes on Microspheres (Large Multivalent Immunogen)1

P. Shrikant, M. Mescher, J. Goldberg, 2003, The Journal of Immunology.

Multivalent Immunogen ) Complexes on Microspheres ( Large CTL Responses by Class I / Peptide Antigen In Vivo Augmentation of Tumor-Specific

P. Shrikant, M. Mescher, J. Goldberg, 2002 .

Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics.

K. Schwertfeger, J. Goldberg, 2010, Current drug targets.

HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family

A. Krensky, C. Clayberger, C. Naftzger, 1996, The Journal of experimental medicine.

A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry.

S. Sherwood, C. Clayberger, J. Goldberg, 1999, Journal of immunological methods.

Membrane progesterone receptor expression in mammalian tissues: A review of regulation and physiological implications

C. Lange, K. Schwertfeger, Gwen E. Dressing, 2011, Steroids.

Complexity and differential expression of carbohydrate epitopes associated with L-selectin recognition of high endothelial venules.

E. Berg, E. Butcher, Eugene C. Butchert, 1998, The American journal of pathology.

Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor

K. Schwertfeger, J. Goldberg, Lindsey K. Bade, 2011, Journal of Cell Science.

Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation.

J. Koopmeiners, N. Brady, S. Schmechel, 2014, Cancer research.

Structure-activity studies of CTL inhibitory peptides derived from HLA class I molecules

J. Griffin, A. Krensky, C. Clayberger, 1997 .